Modified transposases for improved insertion sequence bias and increased DNA input tolerance
Presented herein are transposase enzymes and reaction conditions for improved fragmentation and tagging of nucleic acid samples, in particular altered transposases and reaction conditions which exhibit improved insertion sequence bias, as well as methods and kits using the same.
1. A mutant Tn5 transposase having transposase activity, wherein the mutant Tn5 transposase comprises all of SEQ ID NO:1 except for:
(a) a mutation at the position corresponding to position 120 of SEQ ID NO:1, and optionally
(b) mutations at one or more positions corresponding to positions 54, 56, 119, 125, 248, and 372 of SEQ ID NO:1.
2. The mutant Tn5 transposase of claim 1 , wherein said mutant Tn5 transposase comprises all of SEQ ID NO:1 except for:
(a) a mutation at the position corresponding to position 120 of SEQ ID NO:1, and
(b) mutations at one or more positions corresponding to positions 54, 56, and 372 of SEQ ID NO:1, and optionally
(c) mutations at one or more positions corresponding to positions 119, 125, and 248 of SEQ ID NO:1.
3. The mutant Tn5 transposase of claim 1 , wherein said mutant Tn5 transposase comprises all of SEQ ID NO:1 except for:
(a) a mutation at the position corresponding to position 120 of SEQ ID NO:1, and
(b) mutations at the positions corresponding to positions 54, 56, and 372 of SEQ ID NO:1, and optionally
(c) mutations at one or more positions corresponding to positions 119, 125, and 248 of SEQ ID NO:1.
4. The mutant Tn5 transposase of claim 1 , wherein said mutant Tn5 transposase comprises all of SEQ ID NO:1 except for:
(a) a mutation at the position corresponding to position 120 of SEQ ID NO:1, and optionally,
(b) mutations at the positions corresponding to positions 54, 56, and 372 of SEQ ID NO:1, and
(c) mutations at one or more positions corresponding to positions 119, 125, and 248 of SEQ ID NO:1.
5. The mutant Tn5 transposase of claim 1 , wherein said mutant Tn5 transposase comprises all of SEQ ID NO:1 except for:
(a) a mutation at the position corresponding to position 120 of SEQ ID NO:1, and
(b) mutations at the positions corresponding to positions 54, 56, and 372 of SEQ ID NO:1, and
(c) mutations at one or more positions corresponding to positions 119, 125, and 248 of SEQ ID NO:1.
6. The mutant Tn5 transposase of claim 4 or claim 5 , comprising mutations at positions corresponding to positions 119, 125, and 248 of SEQ ID NO:1.
7. The mutant Tn5 transposase of claim 1 , wherein the mutant Tn5 transposase comprises a substitution at the position corresponding to position 120 of SEQ ID NO:1.
8. The mutant Tn5 transposase of claim 7 , wherein the mutant Tn5 transposase comprises Y, F, E, or W at the position corresponding to position 120 of SEQ ID NO:1.
9. The mutant Tn5 transposase of claim 8 , wherein the mutant Tn5 transposase comprises F at the position corresponding to position 120 of SEQ ID NO:1.
10. The mutant Tn5 transposase of claim 1 , wherein said mutant Tn5 transposase comprises all of SEQ ID NO:1 except for mutations at positions corresponding to positions 54, 56, 120, and 372 of SEQ ID NO:1.
11. The mutant Tn5 transposase of claim 1 , wherein said mutant Tn5 transposase comprises all of SEQ ID NO:1 except for mutations at positions corresponding to positions 54, 56, 119, 120, 125, 248, and 372 of SEQ ID NO:1.
12. The mutant Tn5 transposase of claim 1 , wherein said mutant Tn5 transposase comprises all of SEQ ID NO:1 except for mutations at positions corresponding to positions 119, 120, 125, and 248 of SEQ ID NO:1.
13. The mutant Tn5 transposase of claim 1 , wherein the mutant Tn5 transposase comprises Y, T, K, S, L, A, W, P, G, R, F, or H at the position corresponding to position 248 of SEQ ID NO:1.
14. The mutant Tn5 transposase of claim 1 , wherein the mutant Tn5 transposase comprises L, M, S, A, or V at the position corresponding to position 119 of SEQ ID NO:1.
15. The mutant Tn5 transposase of claim 1 , wherein the mutant Tn5 transposase comprises M at the position corresponding to position 125 of SEQ ID NO:1.
16. A fusion protein comprising the mutant Tn5 transposase of claim 1 and a polypeptide fusion domain.
17. The fusion protein of claim 16 , wherein the polypeptide fusion domain comprises a tag to increase solubility.
18. The fusion protein of claim 17 , wherein the polypeptide fusion domain comprises a domain selected from the group consisting of maltose binding protein (MBP), elongation factor Ts (Tsf), 5-methyl cytosine binding domain, and protein A.
19. A kit for performing an in vitro transposition reaction, wherein the kit comprises a transposome complex, wherein the transposome complex comprises the mutant Tn5 transposase of claim 1 and a polynucleotide, wherein the 3′ portion of the polynucleotide comprises a transposon end sequence.